🇺🇸 FDA
Patent

US 8088787

Methods related to the treatment of neurodegenerative and inflammatory conditions

granted A61KA61K31/19A61K31/46

Quick answer

US patent 8088787 (Methods related to the treatment of neurodegenerative and inflammatory conditions) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/19, A61K31/46, A61K31/485, A61K38/06